The treatment of inflammatory demyelination includes both immunotherapy, which targets the cause of the disease, and supportive therapy, which promotes the recovery of nerve function. Immunotherapy most often uses hormones, immunosuppressants, and gammaglobulin, the main role is to inhibit the inflammatory response, reduce the inflammation of nerve damage, depending on the specific type of disease, whether the patient is prone to relapse, etc., to determine the specific drugs and the course of treatment, generally in the acute phase is the use of high-dose methylprednisolone shock therapy, and then gradually reduce the amount and change to prednisone oral maintenance for a period of time. If the patient is prone to relapse, long-term treatment with hormones or combined immunosuppressive agents such as azathioprine is required. If the disease is prone to recurrence, long-term treatment with hormones or immunosuppressive agents such as azathioprine is required. Symptomatic neurotropic support therapy is usually provided with cytarabine, idebenone, vitamin B1, methylcobalamin, and olanzapine, all of which promote nerve cell metabolism and myelin repair.